BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8705012)

  • 1. Evaluation of disease activity by laboratory tests in juvenile rheumatoid arthritis.
    Martínez-Cordero E; Orozco Barocio G; Martínez Miranda E
    J Investig Allergol Clin Immunol; 1995; 5(4):216-20. PubMed ID: 8705012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoantibodies in juvenile rheumatoid arthritis. Clinical and serologic study].
    Martínez-Cordero E; Martínez-Miranda E; Negrete-García MC; Treviño-Pérez SC
    Bol Med Hosp Infant Mex; 1989 May; 46(5):316-21. PubMed ID: 2757772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parameters.
    Spadaro A; Riccieri V; Sili Scavalli A; Sensi F; Fiore D; Taccari E; Zoppini A
    Rev Rhum Engl Ed; 1996 Mar; 63(3):171-7. PubMed ID: 8731234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of some inflammatory and immune parameters in juvenile rheumatoid arthritis during the acute phase and in remission].
    Bardare M; Besana C; Borroni C; D'Angelo R; Procaccia S; Ortolani C; Zapparoli B
    Boll Ist Sieroter Milan; 1980 Mar; 59(1):35-45. PubMed ID: 7459014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoglobulin and complement interrelationships in juvenile rheumatoid arthritis.
    Gutowska-Grzegorczyk G; Baum J
    J Rheumatol; 1977; 4(2):179-85. PubMed ID: 881695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6 and autoantibodies in juvenile rheumatoid arthritis.
    Oen K; Danell G
    J Rheumatol; 1993 Nov; 20(11):1949-56. PubMed ID: 8308784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and concentration of IgM rheumatoid factor in polyarticular onset disease as compared to systemic or pauciarticular onset disease in active juvenile rheumatoid arthritis as measured by ELISA.
    Walker SM; Shaham B; McCrudy DK; Wietting H; Arora YK; Hanson V; Bernstein B
    J Rheumatol; 1990 Jul; 17(7):936-40. PubMed ID: 2213760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hidden IgM rheumatoid factor in chronic juvenile arthritis. An open multicenter diagnostic study].
    Dippell J
    Monatsschr Kinderheilkd; 1989 Sep; 137(9):606-9. PubMed ID: 2811884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of the presence of hidden 19S IgM rheumatoid factor in juvenile rheumatoid arthritis.
    Moore TL; Dorner RW; Sheridan PW; Weiss TD; Baldassare AR; Osborn TG; Zuckner J
    J Rheumatol; 1982; 9(4):599-602. PubMed ID: 6215487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities in the distribution of serum immunoglobulin concentrations in juvenile rheumatoid arthritis.
    Cassidy JT; Petty RE; Sullivan DB
    J Clin Invest; 1973 Aug; 52(8):1931-6. PubMed ID: 4578296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Juvenile rheumatoid arthritis: Characterisation of its clinical variations (author's transl)].
    González T; Cortabarría C; Bueno M
    An Esp Pediatr; 1975; 8(6):670-6. PubMed ID: 1211694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for the detection of hidden IgM rheumatoid factor in patients with juvenile rheumatoid arthritis.
    Magsaam J; Ferjencik P; Tempels M; Dippell J
    J Rheumatol; 1987 Oct; 14(5):964-7. PubMed ID: 3430524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble adhesion molecules in juvenile rheumatoid arthritis.
    Bloom BJ; Miller LC; Tucker LB; Schaller JG; Blier PR
    J Rheumatol; 1999 Sep; 26(9):2044-8. PubMed ID: 10493690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis.
    Takei S; Imanaka H; Maeno N; Shigemori M; Masuda K; Hokonohara M; Miyata K
    J Rheumatol; 1996 Nov; 23(11):1956-62. PubMed ID: 8923375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombocytosis in juvenile rheumatoid arthritis].
    Frati Munari AC; Martín Alarcón JS; Martínez-Cairo S
    Bol Med Hosp Infant Mex; 1978; 35(6):1109-19. PubMed ID: 687420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.
    Viswanath V; Myles A; Dayal R; Aggarwal A
    J Rheumatol; 2011 Nov; 38(11):2482-7. PubMed ID: 21885500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of rheumatoid factors in juvenile rheumatoid arthritis (chronic polyarthritis) by the photometric latex test.
    Taseski B; Dezelić N; Dezelić G; Grgić M; Vukadinović S
    Z Rheumatol; 1981; 40(1):17-20. PubMed ID: 7223078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
    Dewint P; Hoffman IE; Rogge S; Joos R; Union A; Dehoorne J; Delanghe J; Veys EM; De Keyser F; Elewaut D
    Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.